Cognitive Behavioral Therapy for Social Anxiety Disorder

N/A

Recruiting

Led By Daniel F Gros, PhD MA BS

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to week 6 to week 12 to 6-month followup

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to assess the effectiveness of a therapy (TBT) for Veterans with anxiety/depression disorders, compared to an existing therapy (DST). Assessments will be done before/during/after treatment & 6mos later.

Who is the study for?

This trial is for Veterans registered at Ralph H. Johnson VA Health Care System who have been diagnosed with social anxiety disorder and also show symptoms of posttraumatic stress. They must be able to give informed consent. Specific details on who can't join are not provided.

What is being tested?

The study compares Transdiagnostic Behavior Therapy (TBT), a versatile treatment for various disorders, with Cognitive Behavioral Therapy (CBT) specifically designed for Social Anxiety Disorder in treating veterans with both conditions.

What are the potential side effects?

Since the interventions involve therapy sessions rather than medication, typical side effects associated with drugs may not apply here. However, participants might experience emotional discomfort or distress during therapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to week 6 to week 12 to 6-month followup

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to week 6 to week 12 to 6-month followup

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to week 6 to week 12 to 6-month followup for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Illness Intrusiveness Rating Scale (IIRS)

MASA functional impairment

PTSD Checklist for DSM-5 (PCL-5)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Transdiagnostic Behavior TherapyExperimental Treatment1 Intervention

TBT was developed to address transdiagnostic avoidance via the use of four different types of exposure techniques (situational/in-vivo, physical/interoceptive, thought/imaginal, and \[positive\] emotional/behavioral activation). From the transdiagnostic avoidance perspective, the four exposure practices are matched to the type(s) of avoidance experienced by patients based upon their cluster of symptoms/disorders.

Group II: Cognitive Behavioral Therapy for Social Anxiety DisorderActive Control1 Intervention

To provide an evidence-based comparison for the TBT condition, the research-supported psychological treatment of CBT for SAD will be used. CBT for SAD demonstrates efficacy in improving SAD symptoms and quality of life for patients with SAD, with durable improvements evidenced at follow-up assessments. CBT for SAD was used as a comparison to TBT in previous preliminary research. CBT for SAD involves several primary components, including: 1) psychoeducation, 2) training in cognitive restructuring, 3) exposures, 4) advanced cognitive restructuring, and 5) termination.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Transdiagnostic Behavior Therapy

2014

N/A

~110

Do I qualify?Apply below to find out